Supp. Table 1 from Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in <i>KRAS</i>-Mutant Lung Adenocarcinoma
crossref（2023）
摘要
Supplementary Table S1. KRAS mutant NSCLC patients' characteristics (n=514)
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要